Benzinga | Dec 18, 2020 09:28AM EST

Needham Downgrades BioTelemetry to Hold, Announces $52 Price Target

Needham analyst David Saxon downgrades BioTelemetry (NASDAQ:BEAT) from Buy to Hold and announces $52 price target.